Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a phase 2 clinical trial in which NurOwn’s cell therapy for progressive MS has been found safe and effective.Also, Multiple Sclerosis News Today’s columnist, Jessie Ace reads Jenn Powell’s column where she discusses how to manifest change with secondary progressive multiple sclerosis. =====================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/